145 algorithm-development-"Multiple"-"Simons-Foundation" positions at University College Cork in Ireland
Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
principles of Industrial Pharmaceutical Science, including areas such as Industrial Pharmaceutical Development, Bio/Pharmaceutical Technology, Bio/Pharmaceutical Processing, Pharmaceutical Manufacturing
-
range of matters as well as the opportunity to develop their skills, and knowledge. The Office of Corporate and Legal Affairs operates a hybrid working model in accordance with the University’s Remote
-
, address unmet supportive care needs, and enhance quality of life. Co-developed with survivors, care partners, and healthcare professionals, TRANSCEND-XR will be evidence-based, ethically grounded, and
-
. This EU-funded project focuses on the development and validation of novel Hybrid Blue-Green Infrastructure (HBGI) to enhance shoreline resilience, support biodiversity, and integrate ecological and societal
-
the School of Biochemistry and Cell Biology and in the School of Pharmacy, UCC. The research builds on our significant expertise in developing and commercialising novel vaccines and delivery platforms
-
combination of CFD modelling and running What-if-scenarios to support environmental decision-making and policy development with a focus on vulnerable coastal habitats in Ireland. The successful candidate will
-
demonstrated research achievement, who will contribute to this research programme and will also be supported to prepare for careers in academia or Industry. The successful candidate will join a dynamic team of
-
teaching, curriculum development and research in Physiotherapy. The MSc Physiotherapy programme is located within the School of Clinical Therapies. Over the past number of years, the School has developed a
-
-friendly policies, training and development, and staff networks. We value the enrichment that comes from a diverse community and seek to promote equality, prevent discrimination and protect the human rights
-
developing next-generation antimicrobial peptide (AMP)-based solutions targeting vaginal fungal infections, particularly Recurrent Vulvovaginal Candidiasis (RVVC). The project combines microbiology, molecular